DK0759089T3 - Behandling af glucaner med enzymer - Google Patents

Behandling af glucaner med enzymer

Info

Publication number
DK0759089T3
DK0759089T3 DK95914485T DK95914485T DK0759089T3 DK 0759089 T3 DK0759089 T3 DK 0759089T3 DK 95914485 T DK95914485 T DK 95914485T DK 95914485 T DK95914485 T DK 95914485T DK 0759089 T3 DK0759089 T3 DK 0759089T3
Authority
DK
Denmark
Prior art keywords
glucan
treatment
yeast
glucans
enzymes
Prior art date
Application number
DK95914485T
Other languages
Danish (da)
English (en)
Inventor
Rolf Engstad
Finn Kortner
Borre Robertsen
Gunnar Rorstad
Original Assignee
Biotec Pharmacon Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19897060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0759089(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotec Pharmacon Asa filed Critical Biotec Pharmacon Asa
Application granted granted Critical
Publication of DK0759089T3 publication Critical patent/DK0759089T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95914485T 1994-04-29 1995-04-18 Behandling af glucaner med enzymer DK0759089T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO941581A NO300692B1 (no) 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
PCT/IB1995/000265 WO1995030022A1 (en) 1994-04-29 1995-04-18 Enzyme treatment of glucans

Publications (1)

Publication Number Publication Date
DK0759089T3 true DK0759089T3 (da) 2003-01-06

Family

ID=19897060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914485T DK0759089T3 (da) 1994-04-29 1995-04-18 Behandling af glucaner med enzymer

Country Status (12)

Country Link
US (3) US7883875B2 (enExample)
EP (1) EP0759089B1 (enExample)
JP (3) JP3992730B2 (enExample)
AT (1) ATE222958T1 (enExample)
AU (1) AU703251B2 (enExample)
CA (1) CA2189010C (enExample)
DE (1) DE69527955T2 (enExample)
DK (1) DK0759089T3 (enExample)
ES (1) ES2182898T3 (enExample)
FI (1) FI114807B (enExample)
NO (1) NO300692B1 (enExample)
WO (1) WO1995030022A1 (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300692B1 (no) * 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
DE19911052A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sonnenschutzmittel
DE19911058B4 (de) * 1999-03-12 2004-09-30 Biotec Asa Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
DE19911055A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Verwendung von oberflächenaktiven Gemischen
US8501710B2 (en) * 1999-03-12 2013-08-06 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
US8912165B2 (en) 1999-03-12 2014-12-16 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
DE19911053B4 (de) 1999-03-12 2004-10-28 Biotec Asa Kosmetische und/oder pharmazeutische Zubereitungen
US6875754B1 (en) 1999-03-12 2005-04-05 Biotec Asa Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents
DE19917744A1 (de) * 1999-04-20 2000-10-26 Cognis Deutschland Gmbh Dekorative kosmetische Zubereitungen
DE19917743C2 (de) * 1999-04-20 2003-08-14 Biotec Asa Desodorierende Zubereitungen
DE19920557B4 (de) * 1999-05-05 2004-09-09 Biotec Asa Verfahren zur Herstellung von Kollagenfreien kosmetischen Zubereitungen
US20020009463A1 (en) * 2000-02-23 2002-01-24 Jan Raa Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
GB0211118D0 (en) 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050180964A1 (en) 2003-03-17 2005-08-18 Puntenney Steven B. Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
JP2004210895A (ja) * 2002-12-27 2004-07-29 Immudyne Japan:Kk 免疫機能を有する可能性β−グルカンの製造方法及び用途
JP4416739B2 (ja) 2004-02-13 2010-02-17 株式会社アルプロン 酵母由来グルカンの製造方法
US20050220846A1 (en) 2004-04-05 2005-10-06 Puntenney Steven B Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
AU2004218698B2 (en) * 2004-10-08 2011-06-09 Biotec BetaGlucans AS Method
JP4570949B2 (ja) * 2004-12-13 2010-10-27 株式会社アルプロン 酵母由来グルカンの製造方法
DE602005027915D1 (de) * 2005-08-10 2011-06-16 Omnigen Res Llc VERWENDUNG VON - ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, KIESELGUR, MINERALTON UND GLUCOMANNAN ZUR STEIGERUNG DER IMMUNFUNKTION
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
EP1984004A4 (en) * 2006-01-17 2010-03-03 Sloan Kettering Inst Cancer THE THERAPY REINFORCING GLUCAN
US8142798B2 (en) 2006-04-26 2012-03-27 OmniGen Research, L.L.C. Augmentation of titer for vaccination in animals
US9457047B2 (en) 2006-11-06 2016-10-04 Whitehead Institute Immunomodulating compositions and methods of use thereof
US8580253B2 (en) * 2006-11-06 2013-11-12 Whitehead Institute Immunomodulating compositions and methods of use
TW200900053A (en) 2007-02-21 2009-01-01 Biotec Pharmacon Asa Medical uses of glucans
KR101547970B1 (ko) * 2007-05-08 2015-08-28 바이오테라, 인크. 미립자-가용성 글루칸 제제
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
CA2705544A1 (en) * 2007-11-19 2009-05-28 Calanus As Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
ES2599908T3 (es) 2007-11-26 2017-02-06 Glaxosmithkline Biologicals Sa Glucanos beta-1,3-enlazados conjugados
BRPI0900639C1 (pt) * 2009-02-13 2011-12-20 Hebron Farmaceutica Pesquisa Desenvolvimento E Inovacao Tecnologica Ltda composição farmacêutica e uso desta para tratamento e/ou prevenção de doenças do trato respiratório
EP3130396B1 (en) 2009-03-27 2021-03-17 Bend Research, Inc. Spray-drying process
WO2012014978A1 (ja) * 2010-07-29 2012-02-02 国立大学法人北海道大学 免疫アジュバント
WO2012031129A2 (en) 2010-09-03 2012-03-08 Bend Research, Inc. Spray-drying apparatus and methods of using the same
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
EP2618924A1 (en) 2010-09-24 2013-07-31 Bend Research, Inc. High-temperature spray drying process and apparatus
GB201020193D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
GB201020190D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucans
GB201020191D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan gels
EP2694030A2 (en) 2011-03-04 2014-02-12 Sana Pharma AS Cosmetic formulations
FR2981075A1 (fr) 2011-10-11 2013-04-12 Kitozyme Procede de preparation de glucans a partir d'aspergillus niger
MD4329C1 (ro) * 2013-10-30 2015-09-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Procedeu de cultivare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20
PL3110437T3 (pl) 2014-02-12 2018-04-30 Omnigen Research, Llc Kompozycja i sposób wspomagania obniżania poziomu stresu cieplnego u zwierząt
EP3212169B1 (en) 2014-10-31 2021-01-13 Bend Research, Inc. Process for forming active domains dispersed in a matrix
CN108289479A (zh) 2015-09-09 2018-07-17 奥姆尼根研究有限责任公司 用于水产养殖的组合物和/或组合
WO2022045371A1 (ja) * 2020-08-31 2022-03-03 合同会社レビアスファーマ 組成物およびその組成物の製造方法、脂溶性成分の吸収性を向上させる方法、脂溶性成分の抽出効率を向上させる方法、脂溶性成分

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2764463A (en) 1953-05-26 1956-09-25 Underwood Corp Magnetic recording system
US3954979A (en) * 1972-11-24 1976-05-04 Ceres Products Company, Inc. Process for preparing stabilized yeast and compositions and tableting composition and method
JPS5432076B2 (enExample) 1973-09-14 1979-10-11
JPS54138115A (en) * 1978-04-17 1979-10-26 Kirin Brewery Antiicancer agent
GB2076418A (en) 1980-05-22 1981-12-02 Sankyo Co Hydrolyzed polysaccharide
JPS6019619B2 (ja) 1980-09-19 1985-05-17 株式会社日立製作所 Ｘ線管用回転陽極
SE456911B (sv) 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
JPS60196195A (ja) 1984-03-21 1985-10-04 Dainippon Seito Kk イ−ストグルカンの製造法
US4810646A (en) 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5082936A (en) 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5028703A (en) * 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4992540A (en) 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5057503A (en) * 1989-01-23 1991-10-15 The Brigham And Women's Hospital Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor
CA1330303C (en) 1989-02-20 1994-06-21 Libor Henry Nikl Composition and process to enhance the efficacy of a fish vaccine
EP0490995A1 (en) * 1989-09-08 1992-06-24 Alpha Beta Technology Method for producing soluble glucans
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
ATE153856T1 (de) * 1989-09-08 1997-06-15 Alpha Beta Technology Zusammensetzung zur stimulierung des immunsystems
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan

Also Published As

Publication number Publication date
AU2146495A (en) 1995-11-29
EP0759089A1 (en) 1997-02-26
NO941581L (no) 1995-10-30
ATE222958T1 (de) 2002-09-15
JP2009051863A (ja) 2009-03-12
CA2189010A1 (en) 1995-11-09
US20110104208A1 (en) 2011-05-05
FI964339L (fi) 1996-10-28
JP2007228974A (ja) 2007-09-13
FI114807B (fi) 2004-12-31
JP3992730B2 (ja) 2007-10-17
DE69527955T2 (de) 2003-04-10
DE69527955D1 (de) 2002-10-02
EP0759089B1 (en) 2002-08-28
US20080124349A1 (en) 2008-05-29
US8252295B2 (en) 2012-08-28
WO1995030022A1 (en) 1995-11-09
NO300692B1 (no) 1997-07-07
US8142785B2 (en) 2012-03-27
FI964339A0 (fi) 1996-10-28
US20050255565A1 (en) 2005-11-17
CA2189010C (en) 2010-07-13
AU703251B2 (en) 1999-03-25
ES2182898T3 (es) 2003-03-16
JPH09512708A (ja) 1997-12-22
US7883875B2 (en) 2011-02-08
NO941581D0 (enExample) 1994-04-29

Similar Documents

Publication Publication Date Title
DK0759089T3 (da) Behandling af glucaner med enzymer
ATE71528T1 (de) Loesliches phosphoryliertes glukan.
WO1993007262A3 (en) Purified chitin deacetylase
ID25515A (id) Bahan tumbuhan terfermentasi penghambat rambatan penyakit (metastasis) dan stimulator kekebalan
ES8606906A1 (es) Procedimiento para preparar productos que contienen oligosacaridos a partir de biomasa triturada.
DE69431162D1 (en) Fenbendazolformulierungen
AU2001243667A1 (en) Method of aerating yeast prior to pitching
WO2000078814A3 (en) LO-CD2b ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
Kozhemyakina et al. Conditions of cultivation, composition, and biological activity of mycelium of Flammulina velutipes (Fr.) P. Karst
JPS6442412A (en) Skin-beautifying cosmetic
JPS5381691A (en) Preparation of l-serine
WO2001047962A8 (en) Attenuated microorganisms for the treatment of infection
ES8602113A1 (es) Procedimiento para preparar a-cetoacidos, sus esteres y eteres
WO2001007080A3 (en) Method for enhancing production performance in an animal
WO2001026801A8 (en) Composition of matter tailoring: system i
EP1237093A3 (en) Methods and apparatus for associating character codes with optimized character codes
KR920012448A (ko) 홍국균의 배양방법 및 홍국색소 추출방법
EP0763852A3 (de) Gehäuse für ein Leistungs-Halbleitermodul
杉森尚美 Administration of G-CSF to normal individuals diminishes L-selectin [+] T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin [-] T cells
Rusinov Linear selection of highly productive strains of Penicillium chrysogenum
Burgos Jr We Forum, vol xix No. 2-May 8-14, 1995
UA11935A1 (uk) Гібридhий штам дріжджів sассhаrомyсеs сеrеvіsіае, який використовується для одержання хлібопекарських дріжджів
AMBROSIAE Ñïîðîâ³ ðîñëèíè òà ãðèáè
Kupriyanova-Ashina et al. Effect of the RNase from bacillus intermedius on the trophic organization of the mitotic cycle of candida utilis
JPS57146577A (en) Preparation of amylase g6 of genus bacillus